Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Claudio Martinez-Ballesteros is active.

Publication


Featured researches published by Claudio Martinez-Ballesteros.


European Urology | 2011

Prognostic Impact of the 2009 UICC/AJCC TNM Staging System for Renal Cell Carcinoma with Venous Extension

Juan I. Martínez-Salamanca; William C. Huang; Isabel Millán; Roberto Bertini; Fernando J. Bianco; Joaquín Carballido; Gaetano Ciancio; Carlos de Castro Hernández; Felipe Herranz; A. Haferkamp; Markus Hohenfellner; Brian Hu; Theresa M. Koppie; Claudio Martinez-Ballesteros; Francesco Montorsi; Joan Palou; J. Edson Pontes; Paul Russo; Carlo Terrone; H. Villavicencio; Alessandro Volpe; John A. Libertino

BACKGROUND The prognostic significance of venous involvement and tumour thrombus level in renal cell carcinoma (RCC) remains highly controversial. In 2010, the American Joint Committee on Cancer (AJCC) and the Union International Centre le Cancer (UICC) revised the RCC staging system (7th edition) based on tumour thrombus level, differentiating the T stage of tumours limited to renal-vein-only involvement. OBJECTIVE We aimed to evaluate the impact of tumour thrombus extension in a multi-institutional cohort of patients. DESIGN, SETTING, AND PARTICIPANTS An international consortium of 11 institutions was established to retrospectively review a combined cohort of 1215 patients undergoing radical nephrectomy and tumour thrombectomy for RCC, including 585 patients with inferior vena cava (IVC) involvement or higher. MEASUREMENTS Predictive factors of survival, including histology, tumour thrombus level, nodal status, Fuhrman grade, and tumour size, were analysed. RESULTS AND LIMITATIONS A total of 1122 patients with complete data were reviewed. The median follow-up for all patients was 24.7 mo, with a median survival of 33.8 mo. The 5-yr survival was 43.2% (renal vein involvement), 37% (IVC below the diaphragm), and 22% with caval involvement above the diaphragm. On multivariate analysis, tumour size (hazard ratio [HR]: 1.64 [range: 1.03-2.59]; p=0.036), Fuhrman grade (HR: 2.26 [range: 1.65-3.1]; p=0.000), nodal metastasis (HR: 1.32 [range: 1.09-1.67]; p=0.005), and tumour thrombus level (HR: 2.10 [range: 1.53-3.0]; p=0.00) correlated independently with survival. CONCLUSIONS Based on analysis of the largest known cohort of patients with RCC along with IVC and atrial thrombus involvement, tumour thrombus level is an independent predictor of survival. Our findings support the changes to the latest AJCC/UICC staging system.


Actas Urologicas Espanolas | 2010

[Penile morphometric changes after radical prostatectomy: Evidence-based].

Juan I. Martínez-Salamanca; Claudio Martinez-Ballesteros; Luis del Portillo; Ignacio Moncada; Joaquín Carballido

INTRODUCTION Radical prostatectomy in all its approaches is the treatment of choice for localized prostate cancer and especially in young, sexually active patients with a desire to keep their sex life. In addition to the well-known and defined postoperative erectile dysfunction, erectile silent period causes, in many patients (9-1%), structural changes, in the penile structure, sometimes irreversible. These tissue changes, resulting in a loss of length and girth, that concern patients. OBJECTIVE To systematically review to date published data in the literature regarding penile changes after radical prostatectomy. MATERIAL AND METHODS We performed a systematic search in: PubMed, EMBASE, Cochrane, SCOPUS, Science Citation Index period January 1990 to September 2009 for the terms prostatectomy, organ size, fibrosis, sexual activity, erectile dysfunction, penile size, radical prostatectomy, prostatic neoplasms, body weights and penis measures. Seven series of patients were selected for analysis. RESULTS We described the different measurement methods and their potential biases and differences. Also, we reviewed main physiopathogenic theories to explain this phenomenon. Finally, we detail the results of different series of patients reported. CONCLUSIONS It seems to be a proven fact that the penis undergoes major changes in its length and girth after radical prostatectomy. Several authors have communicated the data of their series and the different treatment options (5PDE inhibitors, vacuum devices, penile extenders, etc.). Strategies addressed to preserve and protect cavernous tissue and tunica albuginea after the procedure, as well as to increase oxygenation and allow erection to be recovered in the shortest possible time positive will impact on the quality of life of our patients.


Archivos españoles de urología | 2010

Fisiología de la erección

Juan I. Martínez-Salamanca; Claudio Martinez-Ballesteros; Luis del Portillo; Sonia Gabancho; Ignacio Moncada; Joaquín Carballido

En este trabajo de revision se repasan los principales mecanismos implicados en el fenomeno de la ereccion humana. Desde sus principios bioquimicos (via oxido nitrico y Rho-quinasa), celulares (mecanismos de relajacion del musculo liso), nerviosos (vias autonomas y somaticas) y finalmente macroscopicos peneanos, son revisados y actualizados con detalle.


The Journal of Urology | 2011

534 CANCER-SPECIFIC SURVIVAL NOMOGRAM FOR RENAL TUMORS WITH VENOUS EXTENSION:INTERNATIONAL RENAL CELL-CARCINOMA-VENOUS THROMBUS CONSORTIUM

Juan I. Martínez-Salamanca; Umberto Capitanio; William J.S. Huang; Isabel Millán; Roberto Bertini; Fernando J. Bianco; Joaquin Carballido Rodriguez; Gaetano Ciancio; Carlos de Castro Hernández; Felipe Herranz Amo; Axel Haferkamp; Markus Hohenfellner; Brian Hu; Theresa M. Koppie; Claudio Martinez-Ballesteros; Francesco Montorsi; Joan Palou; Edson Pontes; Carlo Terrone; Paul Russo; Andrea Sorcini; Alexadro Volpe; John A. Libertino


The Journal of Urology | 2013

1907 LEVEL OF THROMBOUS ACCORDING TO MAYO CLINIC CLASSIFICATION IS AN INDEPENDENT PREDICTOR OF PERIOPERATIVE COMPLICATIONS AND CANCER-RELATED OUTCOME: DATA OF THE IRCVT RCC VENOUS THROMBUS CONSORTIUM

Juan I. Martínez-Salamanca; Giacomo Novara; Roberto Bertini; Joaquín Carballido; Thomas F. Chromecki; Gaetano Ciancio; Sia Daneshmand; Christopher J. Evans; Paolo Gontero; Javier González; Axel Haferkamp; Markus Hohenfellner; William C. Huang; Theresa M. Koppie; Adam Lorentz; Claudio Martinez-Ballesteros; Viraj A. Master; Rayan Matloob; James M. McKiernan; Carrie Mlynarczyk; Francesco Montorsi; Hao G. Nguyen; Sascha Pahernik; Joan Palou; Raj S. Pruthi; Krishna Ramaswamy; Oscar Rodriguez-Faba; Paul Russo; Martin Spahn; Shahrokh F. Shariat


The Journal of Urology | 2011

1813 EFFICACY AND SAFETY OF PENILE EXTENDER DEVICE IN THE TREATMENT OF THE ACUTE PHASE OF PEYRONIE'S DISEASE:A PILOT STUDY

Juan I. Martínez-Salamanca; Alejandra Egui Rojo; Lucia Osorio Cabello; Estefanía Linares Espinós; Ignacio Sola Galarza; Claudio Martinez-Ballesteros; Joaquin Carballido Rodriguez


The Journal of Urology | 2013

259 INTRACAVERNOSAL STEM CELL THERAPY COMBINED WITH ORAL TADALAFIL ADMINISTRATION PRESERVES ERECTILE FUNCTION AFTER CAVERNOUS NERVE INJURY IN RATS

Juan I. Martínez-Salamanca; Mercedes Zurita; Claudio Martinez-Ballesteros; Eduardo Martínez-Salamanca; Argentina Fernández; Pedro Cuevas; Jesús Vaquero; Joaquín Carballido; Carla Costa Costa; J.C. Angulo


The Journal of Urology | 2011

1760 IMPACT OF CARDIOPULMONARY BY-PASS IN CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND LEVEL III/IV THROMBUS. INTERNATIONAL RENAL CELL-CARCINOMA-VENOUS THROMBUS CONSORTIUM

Juan I. Martínez-Salamanca; William J.S. Huang; Umberto Capitanio; Isabel Millán; Roberto Bertini; Fernando J. Bianco; Joaquin Carballido Rodriguez; Gaetano Ciancio; Carlos de Castro Hernández; Felipe Herranz Amo; Axel Haferkamp; Markus Hohenfellner; Brian Hu; Theresa M. Koppie; Claudio Martinez-Ballesteros; Francesco Montorsi; Joan Palou; Edson Pontes; Carlo Terrone; Paul Russo; Andrea Sorcini; Alexadro Volpe; John A. Libertino


The Journal of Urology | 2011

959 THE IMPACT OF LOCAL AND DISTANT METASTASIS ON SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY WITH TUMOR THROMBECTOMY

Jennifer M. Wu; Blythe Durbin-Johnson; Juan I. Martínez-Salamanca; Roberto Bertini; Fernando J. Bianco; Joaquín Carballido; Gaetano Ciancio; Carlos de Castro Hernández; Felipe Herranz; Axel Haferkamp; Markus Hohenfellner; Claudio Martinez-Ballesteros; Francesco Montorsi; Alberto Briganti; Umberto Capitanio; Andrea Sorcini; Joan Palou; J. Edson Pontes; Paul Russo; Carlo Terrone; Alessandro Volpe; John A. Libertino; Christopher P. Evans; William C. Huang; Theresa M. Koppie


Medicine | 2011

Disfunción sexual masculina: clasificación, diagnóstico y manejo actual

Juan I. Martínez-Salamanca; Claudio Martinez-Ballesteros; G. Rodríguez Reina; J. Carballido Rodríguez

Collaboration


Dive into the Claudio Martinez-Ballesteros's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joaquín Carballido

Autonomous University of Madrid

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul Russo

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joan Palou

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Francesco Montorsi

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

Roberto Bertini

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

Ignacio Moncada

St James's University Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge